MONDAY AFTERNOON, May 6, 1991
1:30 p.m. SCIENTIFIC SESSION -
International Ballroom
6. Barrett's Ulcer: A Surgical Disease?
WARREN A.
WILLIAMSON*, F. HENRY ELLIS, JR.,
PETER S. GIBB* and H. THOMAS ARETZ*
Burlington, Massachusetts
Published reports on the treatment of Barrett's
ulcer are controversial and sparse. Our experience with the management of this
disorder over the past 16 years suggests that surgical therapy is rarely
indicated.
Two hundred
eighty-five cases of Barrett's esophagus were treated from 1974 to 1990.
Seventy-three of these patients either presented with adenocarcinoma in
Barrett's or developed it while under surveillance. Of the remaining 212
patients with benign Barrett's esophagus, 30 were found to have Barrett's ulcer
on endoscopy, for a prevalence of 14%. Ulcers varied in size from 0.5cm to 3cm,
sixteen (53%) being 1 cm or larger. Heartburn (70%), dysphagia (60%), and
bleeding or anemia (23%) were the most common presenting symptoms. No patient
exhibited either free perforation or perforation into the mediastinal
structures. Ten patients (30%) admitted to heavy alcohol consumption.
Initial
treatment consisted of aggressive medical therapy including H2
antagonists and antacids as well as the usual dietary and anti-reflux measures.
Three patients were lost to follow-up and twenty-seven were initially
re-endoscoped in 2-4 months. Total endoscopic follow-up was 109 patient-years
with a range of 2 months to 13 years and a median of 2.3 years. Complete
healing occurred in 23 of 27 patients (85%) in two to 14 months (median 4
months). Seven of the 23 (30%) developed recurrent ulceration which healed in
five with further medical therapy. A Nissen fundoplication or a Collis-Nissen
was performed in four of the six patients with non-healing Barrett's ulcers, 1
to 1.5 cm in size, and they subsequently healed. Two patients refused surgery.
We conclude that the majority of Barrett's ulcers
will heal on medical therapy, even large ulcers (2-3cm) and recurrent ulcers.
We reserve surgical intervention for otherwise suitable operative candidates if
there is no evidence of healing of the ulcer after a minimum of four months of
medical therapy and prefer the Nissen fundoplication or one of its
modifications. Perforation, uncontrollable hemorrhage, and malignant
degeneration, not encountered in this series, are of course, indications for
urgent surgical intervention.
*By Invitation
7. Primary Repair of a Wide Spectrum of
Esophageal Atresia
EDWARD M. BOYLE,
JR*, ERICD. IRWIN*
and JOHN E. FOKER
Minneapolis,
Minnesota
Surgical repair
of esophageal atresia (EA) with or without tracheoesophageal fistula (TEF) in
infants with a wide gap length has continued to be a difficult problem. This
study demonstrates, however, that primary repair can be safely carried out in
infants with a wide spectrum of esophageal gap lengths. From 1976 to 1989, 56
infants with EA, with (54) or without (2) associated TEF(s), underwent primary
repair. A very wide gap length (≥ 2.5 cm) existed in 15/56 (27%). Three
infants had gap lengths of 4-7 thoracic vertebrae, two with pure EA and one
with a proximal TEF with a short blind distal segment. These three infants underwent
gastrostomy placement but after six weeks had no significant decrease in gap
length. The wide gap in five other infants was related to an associated
vascular ring. Since 1983 no infant was staged for interposition, even with an
ultrawide gap. All 56 patients had a primary anastomosis without lengthening
procedures such as circular myotomy. Our results include no deaths related to
the operation (0%), nor apparent leaks (0%) nor recurrent TEF's (0%). Eight
(14%)late deaths occurred (16-300 days postop) secondary to prematurity
or other anomalies, thus demonstrating that survival depends on the severity of
associated problems. One infant required a second operation for an unsuspected
cervical TEF. Significant gastroesophageal reflux (GER) was found in 32/56
(57%) and was most common in the wide gap group. Fun-doplication was required
in 13/56 (23%) and severe tracheomalacia was treated by aortopexy in 5/56 (9%)
infants. All patients underwent two prophylactic dilations with 19/56 (34%)
requiring additional dilations of anastomotic narrowing. One patient (2%)
required late resection of an anastomotic stricture. All 48 surviving patients
are now eating a diet normal for age (follow-up 0.75-16 years). In summary: (1)
Primary repair can be reliably performed for the full spectrum of EA defects.
(2) With our technique, a gap which exceeds 2.5 cm does not preclude successful
primary repair despite the resulting great anastomotic tension. (3) With wide
gap EA later operations for GER and the need for additional dilations are more
common. (4) We conclude that infants born with EA can expect an adequately
functioning native esophagus after this type of repair.
*By Invitation
8. Surgery
for Subclavian Vein Effort Thrombosis
J. ERNESTO
MOLINA
Minneapolis,
Minnesota
Effort subclavian vein thrombosis (ESCVTO) occurs
suddenly in young active people without premonitory signs or symptoms. If not
treated as an emergency, permanent disability is common. Our protocol entails
direct lysis of the clot via a catheter in the subclavian vein (Urokinase at
the dose of 3,000 u/kg/wt) for 12-24 hours followed by surgery. The operation
is done via a subclavicular approach for 1st rib resection and subclavian vein
patch angioplasty is done if necessary. Residual stricture is treated with
in-traluminal balloon angioplasty. Out of 27 patients seen, 23 were treated
with this regimen. 16 on the right and 7 on the left. Three groups were
identified: a) acute, < 5 days (6 pts.). Tears in the veins but no
strictures were present, b) sub-acute, > 6 days (7 pts.), stricture present
in 4 patients, c) chronic, > 2 weeks (10 pts.) comprising two categories: 1)
short segment of subtotal obstruction (6 pts.), and 2) long segment of total
obstruction (4 pts.). Vein patency with normal or near normal caliber and flow
was achieved in all of groups a and b, and 7 patients in group c (87%). ESCVT
must be treated as emergency for successful re-establishment of normal vein
patency. The subclavicular approach to the first rib is simple direct and
offers no risk of damaging vital structures. This method is less cumbersome
than the transaxillary or posterior approaches and relieves any type of
vascular thoracic outlet obstruction.
2:30 p.m. BASIC SCIENCE LECTURE
Transplant Immunology: A Broadening of the Concept
for the Future
Fritz H. Bach, M.D., Ph.D.,
Minneapolis, Minnesota
3:15 p.m. INTERMISSION - VISIT EXHIBITS
*By Invitation
4:00 p.m. SCIENTIFIC SESSION -
International Ballroom
9. Transesophageal Echocardiography in the
Emergency Surgical Management of Patients with Aortic Dissection
PAUL SIMON*,
ALYSONNINA OWEN*,
MICHAEL HA VEL*,
ERNST WOLNER,
MICHAEL HIESMAYR*
and WERNER MOHL*
Vienna, Austria
To investigate the benefit of transesophageal
echocardiography (TEE) in the diagnosis of aortic Type A dissection, 15
consecutive patients were studied.
Patients were evaluated immediately upon admission.
The intimal flap was visualized in all 15 patients. The primary entry site was
correctly identified in 14 patients (93%). The entry site which was
misdiagnosed by TEE was also misdiagnosed by angiography and NMR. Significant
aortic regurgitation was encountered in 2 patients and mild insufficiency in 3.
Involvement of the coronary arteries was ruled out in all patients. Pericardial
tamponade necessitating immediate surgery was detected in one case. Five
patients of this series underwent surgery based on TEE alone. Intraoperative
TEE monitoring was used to verify retrograde flow in the true lumen after
femoral can-nulation. The surgical result was evaluated immediately after
termination of cardio-pulmonary bypass. TEE documented no flow in the false
lumen in 13 patients. In two patients small intimal tears were detected in the
descending thoracic aorta. Aortic regurgitation had resolved in all patients.
We conclude that TEE allows expedient diagnosis of
type A aortic dissections and recommend TEE as the primary bedside diagnostic
modality. It can especially be used to identify patients requiring surgical
intervention without further delay due to other diagnostic procedures.
*By Invitation
10. Atheroembolism from the Ascending Aorta: An
Emerging Problem in Cardiac Surgery
CHRISTOPHER I.
BLAUTH*, BRIAN WEBB*,
NORMAN B. RATLIFF*,
BRUCE W. LYTLE,
FLOYD D. LOOP and
DELOS M. COSGROVE
Cleveland, Ohio
As
patients undergoing cardiac surgery increase in age, noncardiac causes of death
have increased. To identify these causes, autopsy findings in 221 patients
undergoing myocardial revascularization or valve surgery, between 1982 and
1989, were analyzed. Mean age was 65.6 ± 9.5 and ranged from 32 to 94 years;
130 (58.7%) were males. Autopsies were complete in 129 patients (58.4%) and
limited to the chest and abdomen in the remainder.
Embolic pathology was identified in 69 patients
(31.2%). Atheroemboli or pathology consistent with atheroemboli were identified
in 48 (21.7%). Fourteen had thromboembolism; 7 had disseminated intravascular
coagulation. The incidence of atheroembolic pathology increased dramatically
from 4.5% in 1982 to 48.2% in 1989 (p<0.0001). Atheroembolic pathology was
found in the brain in 16.3%, spleen in 10.9%, kidney in 10.4%, and pancreas in
6.8%. Thirty (62.5%) of the patients had multiple atheroembolic sites.
Atheroemboli were more common in patients undergoing coronary artery procedures
(43/165; 26.1%) than in those undergoing valve procedures (5/56; 8.9%) (p =
0.008).
There was a high correlation of atheroemboli with
severe ascending aortic atherosclerosis. Atheroembolic events occurred in 46 of
123 patients (37.4%) with severe disease of the ascending aorta but only 2 in
98 patients (2%) without significant ascending aortic disease (p<0.0001).
Forty-six of 48 patients (95.8%) who had evidence of atheroemboli had severe
atherosclerosis of the ascending aorta.
There was a direct correlation between age, severe
atherosclerosis of the ascending aorta, and atheroemboli.
|
Patient age
|
<60
|
61-70
|
≥70
|
p Value
|
|
|
N = 46
|
N = 96
|
N = 79
|
|
|
Aortic atherosclerosis
|
26.1%
|
61.5%
|
65.8%
|
<0.001
|
|
Atheroemboli
|
10.9%
|
20.8%
|
29.1%
|
0.05
|
We conclude that atheroembolism to the brain and
other organs is emerging as a major problem in cardiac surgery, particularly in
patients having coronary operations. The incidence correlates directly with age
and severe atherosclerosis of the ascending aorta.
*By Invitation
11. Management of the Severely Atherosclerotic
Aorta During Cardiac Operations: A Strategy for Detection and Treatment
THOMAS H. WAREING*,
VICTOR G. DAVILA-ROMAN*,
BENICO BARZILAI",
SUZAN F. MURPHY*
and NICHOLAS T.
KOUCHOUKOS
St. Louis, Missouri
Embolization
of atheroma from manipulation of the ascending aorta is one of the principal
causes of stroke following cardiac surgical procedures. We have previously
shown that intraoperative ultrasonographic scanning of the aorta using a high
frequency (7.0 MHz) linear ultrasound transducer with longitudinal and
transverse views rapidly, safely, and accurately identifies severe atheromatous
disease in the ascending aorta and is far more effective for diagnosis than
palpation of the aorta. Intraoperative ultrasonography of the ascending aorta
was performed in 331 of a consecutive series of 362 patients (pts) 50 years of
age or older (mean 69 years) who underwent a variety of cardiac surgical
procedures. Forty-eight patients (14.5%) with a mean age of 72 years (range
55-85 years) were identified as having significant atheromatous disease in the
ascending aorta at the usual sites for cannulation or clamping or diffusely
throughout the ascending aorta, and were considered to be at increased risk for
embolization. Palpation identified the disease in only 23 (48%) of these
patients. A total of 107 modifications in the standard techniques for
cannulation and clamping of the aorta were implemented. These included
alterations in the sites of aortic cannulation (35 pts), aortic clamping (34
pts), attachment of the vein grafts (23 pts), and cannulation for infusion of
cardioplegia (15 pts). Additionally, 8 patients with severe diffuse
atheromatous disease underwent graft replacement of the ascending aorta using
hypothermic circulatory arrest without aortic clamping, and one patient
underwent coronary artery bypass grafting with femoral artery cannulation,
hypothrmic fibrillatory arrest and internal mammary artery grafts. Thirty day
mortality for the entire group was 2.4% (8 pts). Permanent neurological
deficits occurred in 5 (1.5%) of the patients in the entire group but in none
of the 48 patients with significant atheromatous disease in whom modifications
in technique were employed.
We conclude that intraoperative ultrasonic imaging
is currently the most reliable method of assessing the ascending aorta for the
presence of severe atheromatous disease. Modification of standard cannulation
and clamping techniques based on ultrasonography may reduce the frequency of
stroke related to atheromatous embolization.
*By Invitation